Journal
BRITISH JOURNAL OF CANCER
Volume 107, Issue 9, Pages 1525-1533Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/bjc.2012.421
Keywords
pharmacokinetics; telomere length; 5FU toxicity; platelet lymphocyte ratio; colorectal cancer
Categories
Funding
- Calvary Mater Newcastle Hospital
- University of Newcastle, NSW Australia
Ask authors/readers for more resources
BACKGROUND: Identifying various pretreatment factors that predict chemotherapy-induced toxicity in colorectal cancer (CRC) patients undergoing treatment for their disease is crucial to optimising patient care. METHODS: Seventy-three patients received adjuvant 5-fluorouracil (5FU)/leucovorin using either the Mayo Clinic (n = 42) or a weekly schedule (n = 31) and evaluated for clinical toxicity. Pretreatment blood analysis included measures of plasma uracil and dihydrouracil, peripheral blood mononuclear cell (PBMNC) telomere length (TL), standard biochemistry and cell differential analysis. On the first day of treatment 5FU-pharmacokinetic variables of area under the curve, half life and clearance were also measured. These variables together with age and gender were used in univariate and multivariate analysis as predictors of clinical toxicity. RESULTS: For the Mayo schedule the primary toxicities were neutropenia (69%), mucositis (58%) and leukopenia (46%), with 70% of patients presenting with haematological toxicity >= grade 1 (neutropenia and/or leukopenia). Multivariate analysis showed that haematological toxicity was predicted by short TL, high platelet lymphocyte ratio (PLR) and low neutrophil count (R-2 = 0.38, P<0.0006), whereas mucositis was predicted by age, TL and PLR (R-2 = 0.34, P<0.001). For the weekly schedule diarrhoea predominated (16%), with female gender as the only predictive factor. Although measures of uracil metabolism correlated well with 5FU metabolism (r = 0.45-0.49), they did not indicate abnormal pyrimidine metabolism in this cohort and not surprisingly failed to predict for 5FU toxicity. CONCLUSION: Short TL of PBMNC and an increased PLR were strong predictors of mucositis and haematological toxicity in CRC patients undergoing 5FU treatment in the adjuvant setting. British Journal of Cancer (2012) 107, 1525-1533. doi:10.1038/bjc.2012.421 www.bjcancer.com Published online 18 September 2012 (C) 2012 Cancer Research UK
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available